Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α ; volume:9 ; number:1 ; day:26 ; month:4 ; year:2012 ; pages:1-17 ; date:12.2012
Journal of neuroinflammation ; 9, Heft 1 (26.4.2012), 1-17, 12.2012
- Urheber
-
Esposito, Emanuela
- Beteiligte Personen und Organisationen
-
Rinaldi, Barbara
Mazzon, Emanuela
Donniacuo, Maria
Impellizzeri, Daniela
Paterniti, Irene
Capuano, Annalisa
Bramanti, Placido
Cuzzocrea, Salvatore
SpringerLink (Online service)
- DOI
-
10.1186/1742-2094-9-81
- URN
-
urn:nbn:de:1111-2016032331529
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Esposito, Emanuela
- Rinaldi, Barbara
- Mazzon, Emanuela
- Donniacuo, Maria
- Impellizzeri, Daniela
- Paterniti, Irene
- Capuano, Annalisa
- Bramanti, Placido
- Cuzzocrea, Salvatore
- SpringerLink (Online service)
Ähnliche Objekte (12)
![RAGE dependent regulation of PPAR-α [PPAR-alpha] in bone metabolism](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
RAGE dependent regulation of PPAR-α [PPAR-alpha] in bone metabolism
Palmitoleate attenuates diet induced insulin resistance and hepatic inflammation independently of PPAR-α
RAGE-deficiency results in reduced PPAR-α [PPAR-alpha] nuclear translocation, proinflammation and altered bone metabolism
Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies
Role of peroxisome proliferator activated receptor α [alpha] (PPARα) [PPAR-alpha] in cardiomyogenesis of mouse embryonic stem cells
Amelioration of High Fructose Diet-Induced Insulin Resistance, Hyperuricemia, and Liver Oxidative Stress by Combined Use of Selective Agonists of PPAR-α and PPAR-γ in Rats
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
Expressionsanalyse von Tumorprogressionsmarkern im Pankreaskarzinom am Beispiel von CD24, PLK-1 und PPAR-ã
The role of PPAR-γ in establishment of GC-induced anti-inflammatory phenotype in macrophages
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
Modulation inflammatorischer Atherosklerosemarker durch Peroxisome proliferator-activated receptor-alpha (PPARα)]-aktivierendes [(PPAR-alpha)-aktivierendes] Fenofibrat
Virtuelles Screening und De-Novo-Design von PPARα-Agonisten [PPAR-alpha-Agonisten] mit Oberflächen-Deskriptoren
RAGE dependent regulation of PPAR-α [PPAR-alpha] in bone metabolism
Palmitoleate attenuates diet induced insulin resistance and hepatic inflammation independently of PPAR-α
RAGE-deficiency results in reduced PPAR-α [PPAR-alpha] nuclear translocation, proinflammation and altered bone metabolism
Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies
Role of peroxisome proliferator activated receptor α [alpha] (PPARα) [PPAR-alpha] in cardiomyogenesis of mouse embryonic stem cells
Amelioration of High Fructose Diet-Induced Insulin Resistance, Hyperuricemia, and Liver Oxidative Stress by Combined Use of Selective Agonists of PPAR-α and PPAR-γ in Rats
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
Expressionsanalyse von Tumorprogressionsmarkern im Pankreaskarzinom am Beispiel von CD24, PLK-1 und PPAR-ã
The role of PPAR-γ in establishment of GC-induced anti-inflammatory phenotype in macrophages
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
Modulation inflammatorischer Atherosklerosemarker durch Peroxisome proliferator-activated receptor-alpha (PPARα)]-aktivierendes [(PPAR-alpha)-aktivierendes] Fenofibrat
Virtuelles Screening und De-Novo-Design von PPARα-Agonisten [PPAR-alpha-Agonisten] mit Oberflächen-Deskriptoren
RAGE dependent regulation of PPAR-α [PPAR-alpha] in bone metabolism
Palmitoleate attenuates diet induced insulin resistance and hepatic inflammation independently of PPAR-α
RAGE-deficiency results in reduced PPAR-α [PPAR-alpha] nuclear translocation, proinflammation and altered bone metabolism
Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies
Role of peroxisome proliferator activated receptor α [alpha] (PPARα) [PPAR-alpha] in cardiomyogenesis of mouse embryonic stem cells
Amelioration of High Fructose Diet-Induced Insulin Resistance, Hyperuricemia, and Liver Oxidative Stress by Combined Use of Selective Agonists of PPAR-α and PPAR-γ in Rats
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
Expressionsanalyse von Tumorprogressionsmarkern im Pankreaskarzinom am Beispiel von CD24, PLK-1 und PPAR-ã
The role of PPAR-γ in establishment of GC-induced anti-inflammatory phenotype in macrophages
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
Modulation inflammatorischer Atherosklerosemarker durch Peroxisome proliferator-activated receptor-alpha (PPARα)]-aktivierendes [(PPAR-alpha)-aktivierendes] Fenofibrat